Kejixin (Afatinib) 30mg Tablets | Kelun China Generic | GLT

Generic Information: Kejixin (Afatinib) — Kelun, China

Kejixin is a domestic Chinese generic of afatinib produced by Hunan Kelun Pharmaceutical Co., Ltd., a subsidiary of the Kelun Pharmaceutical group. This listing covers the 30 mg strength in a 30-tablet pack, which is particularly useful as the reduced-dose option for patients who need dose adjustment or have severe renal impairment. Kelun was the fourth company in China to obtain afatinib generic approval, and its product passed the national consistency evaluation, confirming bioequivalence to the originator.

What Is Kejixin (Afatinib) Used For?

Kejixin is used to treat non-small cell lung cancer with EGFR-activating mutations, including exon 19 deletions and the L858R substitution, as well as uncommon mutations such as G719X, L861Q and S768I. It is a first-line option for EGFR-mutant NSCLC and is also indicated for metastatic squamous NSCLC that has progressed after platinum-based chemotherapy. The 30 mg strength is commonly used for dose reduction or in patients with impaired kidney function.

How Does Kejixin (Afatinib) Work?

Kejixin contains afatinib, an irreversible pan-ErbB tyrosine kinase inhibitor. It covalently binds the kinase domains of EGFR, HER2 and ErbB4, permanently blocking the growth signals that EGFR-mutant lung cancer cells depend on. This irreversible mechanism provides durable tumor control and covers uncommon EGFR mutations, distinguishing afatinib from reversible first-generation inhibitors.

Indications

Kejixin is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer with non-resistant EGFR mutations, and for metastatic squamous NSCLC progressing on or after platinum-based therapy. EGFR mutation testing is required before treatment.

Dosage

The standard afatinib dose is 40 mg once daily; the 30 mg strength is used for patients with severe renal impairment or when dose reduction is needed to manage tolerability. Kejixin 30 mg should be taken once daily on an empty stomach — at least one hour before or two hours after food. The 30-tablet pack is approximately one month of therapy.

Side Effects

The side effects of Kejixin are consistent with afatinib: diarrhea, acneiform rash, stomatitis, paronychia, dry skin and decreased appetite are the most common. Serious reactions such as interstitial lung disease, hepatotoxicity and severe skin disorders are uncommon but require prompt medical attention. Proactive management of diarrhea and skin symptoms is recommended.

Storage

Store Kejixin in a cool, dry place away from sunlight and moisture, in its original packaging. Keep out of reach of children and swallow tablets whole with water.

Why Choose the GLT?

Kejixin through GLT offers a consistency-evaluated domestic generic in the 30 mg strength, ideal for patients who need a reduced dose or have kidney impairment. As a Hong Kong-licensed supplier, we provide genuine stock and the documentation needed for confident purchasing. For patients and institutions seeking an affordable, quality-assured 30 mg afatinib, Kejixin is a practical and dependable option.

How to Order Kejixin (Afatinib)

Contact us on WhatsApp at +86 15234153837 or by email at [email protected] to order. Share your quantity and destination, and we will confirm availability, pricing and delivery.

FAQ

Who makes Kejixin? Kejixin is produced by Hunan Kelun Pharmaceutical Co., Ltd., part of the Kelun Pharmaceutical group and China's fourth afatinib generic to gain approval.

Why choose the 30 mg strength? The 30 mg dose is used for patients with severe renal impairment or when a dose reduction is needed to improve tolerability.

Is Kejixin equivalent to the originator? Yes, Kejixin passed the national consistency evaluation, confirming bioequivalence to the originator afatinib.

Do I need a prescription? Yes, afatinib is a prescription oncology medicine used under physician supervision.